650 related articles for article (PubMed ID: 19719968)
1. Modulation of NRF2 and UGT1A expression by epigallocatechin-3-gallate in colon cancer cells and BALB/c mice.
Zhang ZM; Yang XY; Yuan JH; Sun ZY; Li YQ
Chin Med J (Engl); 2009 Jul; 122(14):1660-5. PubMed ID: 19719968
[TBL] [Abstract][Full Text] [Related]
2. [The role of NF-E2-related factor 2 in the induction of uridine 5'-diphosphate-glucuronosyltransferase 1A and its isoforms by epigallocatechin gallate in colon cancer cells].
Yang XY; Zhao WP; Li YQ; Sun ZY; Zhang Y; Guo YT; Yuan JH; Zhu Q; Wang M
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):82-7. PubMed ID: 16620709
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of epigallocatechin gallate on orthotopic colon cancer by upregulating the Nrf2-UGT1A signal pathway in nude mice.
Yuan JH; Li YQ; Yang XY
Pharmacology; 2007; 80(4):269-78. PubMed ID: 17657175
[TBL] [Abstract][Full Text] [Related]
4. Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits cyclooxygenase-2 expression in colon carcinogenesis.
Peng G; Dixon DA; Muga SJ; Smith TJ; Wargovich MJ
Mol Carcinog; 2006 May; 45(5):309-19. PubMed ID: 16508969
[TBL] [Abstract][Full Text] [Related]
5. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
[TBL] [Abstract][Full Text] [Related]
6. (-)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells.
Kim M; Murakami A; Kawabata K; Ohigashi H
Carcinogenesis; 2005 Sep; 26(9):1553-62. PubMed ID: 15860507
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of epigallocatechin gallate on colon preneoplastic lesions induced by 2-amino-3-methylimidazo[4,5-f ] quinoline in mice.
Yuan JH; Li YQ; Yang XY
Mol Med; 2008; 14(9-10):590-8. PubMed ID: 18596869
[TBL] [Abstract][Full Text] [Related]
8. Induction of CYP1A by green tea extract in human intestinal cell lines.
Netsch MI; Gutmann H; Schmidlin CB; Aydogan C; Drewe J
Planta Med; 2006 May; 72(6):514-20. PubMed ID: 16773535
[TBL] [Abstract][Full Text] [Related]
9. The green tea compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells.
Rieger-Christ KM; Hanley R; Lodowsky C; Bernier T; Vemulapalli P; Roth M; Kim J; Yee AS; Le SM; Marie PJ; Libertino JA; Summerhayes IC
J Cell Biochem; 2007 Oct; 102(2):377-88. PubMed ID: 17348027
[TBL] [Abstract][Full Text] [Related]
10. EGCG inhibits growth and induces apoptosis in renal cell carcinoma through TFPI-2 overexpression.
Gu B; Ding Q; Xia G; Fang Z
Oncol Rep; 2009 Mar; 21(3):635-40. PubMed ID: 19212621
[TBL] [Abstract][Full Text] [Related]
11. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells.
Jung YD; Kim MS; Shin BA; Chay KO; Ahn BW; Liu W; Bucana CD; Gallick GE; Ellis LM
Br J Cancer; 2001 Mar; 84(6):844-50. PubMed ID: 11259102
[TBL] [Abstract][Full Text] [Related]
12. EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis.
Mittal A; Pate MS; Wylie RC; Tollefsbol TO; Katiyar SK
Int J Oncol; 2004 Mar; 24(3):703-10. PubMed ID: 14767556
[TBL] [Abstract][Full Text] [Related]
13. A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins.
Nishikawa T; Nakajima T; Moriguchi M; Jo M; Sekoguchi S; Ishii M; Takashima H; Katagishi T; Kimura H; Minami M; Itoh Y; Kagawa K; Okanoue T
J Hepatol; 2006 Jun; 44(6):1074-82. PubMed ID: 16481065
[TBL] [Abstract][Full Text] [Related]
14. The Survivin-mediated radioresistant phenotype of glioblastomas is regulated by RhoA and inhibited by the green tea polyphenol (-)-epigallocatechin-3-gallate.
McLaughlin N; Annabi B; Bouzeghrane M; Temme A; Bahary JP; Moumdjian R; Béliveau R
Brain Res; 2006 Feb; 1071(1):1-9. PubMed ID: 16412397
[TBL] [Abstract][Full Text] [Related]
15. Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression.
Tang Y; Zhao DY; Elliott S; Zhao W; Curiel TJ; Beckman BS; Burow ME
Int J Oncol; 2007 Oct; 31(4):705-11. PubMed ID: 17786300
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional responses to epigallocatechin-3 gallate in HT 29 colon carcinoma spheroids.
McLoughlin P; Roengvoraphoj M; Gissel C; Hescheler J; Certa U; Sachinidis A
Genes Cells; 2004 Jul; 9(7):661-9. PubMed ID: 15265009
[TBL] [Abstract][Full Text] [Related]
17. Model of inhibition of Thermus aquaticus polymerase and Moloney murine leukemia virus reverse transcriptase by tea polyphenols (+)-catechin and (-)-epigallocatechin-3-gallate.
Tichopad A; Polster J; Pecen L; Pfaffl MW
J Ethnopharmacol; 2005 Jun; 99(2):221-7. PubMed ID: 15894131
[TBL] [Abstract][Full Text] [Related]
18. The specific anti-cancer activity of green tea (-)-epigallocatechin-3-gallate (EGCG).
Wang YC; Bachrach U
Amino Acids; 2002; 22(2):131-43. PubMed ID: 12395181
[TBL] [Abstract][Full Text] [Related]
19. (-)-Epigallocatechin gallate suppresses azoxymethane-induced colonic premalignant lesions in male C57BL/KsJ-db/db mice.
Shimizu M; Shirakami Y; Sakai H; Adachi S; Hata K; Hirose Y; Tsurumi H; Tanaka T; Moriwaki H
Cancer Prev Res (Phila); 2008 Sep; 1(4):298-304. PubMed ID: 19138973
[TBL] [Abstract][Full Text] [Related]
20. EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells.
Shimizu M; Deguchi A; Joe AK; Mckoy JF; Moriwaki H; Weinstein IB
J Exp Ther Oncol; 2005; 5(1):69-78. PubMed ID: 16416603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
